Cellular mechanisms in the pathogenesis of interstitial lung diseases

被引:1
|
作者
Singh, Priyanka [1 ,2 ,3 ,4 ]
Ali, Saba Naaz [1 ,2 ,3 ,4 ]
Zaheer, Sufian [1 ,2 ,3 ,4 ]
Singh, Mukul [1 ,2 ,3 ,4 ]
机构
[1] VMMC, Dept Pathol, 4th Floor,Coll Bldg, New Delhi 110029, India
[2] Safdarjang Hosp, New Delhi 110029, India
[3] Vardhman Mahavir Med Coll, Dept Pathol, New Delhi 29, India
[4] Safdarjang Hosp, New Delhi 29, India
关键词
Idiopathic pulmonary fibrosis; Interstitial lung disease; Pulmonary fibrosis; Myofibroblast; IDIOPATHIC PULMONARY-FIBROSIS; EPITHELIAL-MESENCHYMAL TRANSITION; RESIDENT FIBROBLASTS; STEM-CELLS; PROLIFERATION; MYOFIBROBLAST; EXPRESSION; TRANSCRIPTION; MUTATIONS; RECEPTORS;
D O I
10.1016/j.prp.2023.154691
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The interstitial lung diseases (ILDs) are a large, heterogeneous group of several hundred generally rare pulmonary pathologies, which show injury, inflammation and/or scarring in the lung. Although the aetiology of these disorders remains largely unknown, various cellular mechanisms have an important role in pathogenesis of fibrosis on the background of occupational, environmental and genetic factors. We have tried to provide new insights into the interactions and cellular contributions, analysing the roles of various cells in the pathogenesis of idiopathic pulmonary fibrosis.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Angiogenesis in Interstitial Lung Diseases: a pathogenetic hallmark or a bystander?
    Argyris Tzouvelekis
    Stavros Anevlavis
    Demosthenes Bouros
    Respiratory Research, 7
  • [22] Speaking of the "Devil": Diagnostic Errors in Interstitial Lung Diseases
    Arcana, Raluca Ioana
    Crisan-Dabija, Radu Adrian
    Caba, Bogdan
    Zamfir, Alexandra-Simona
    Cernomaz, Tudor Andrei
    Zabara-Antal, Andreea
    Zabara, Mihai Lucian
    Arcana, Stefanita
    Marcu, Dragos Traian
    Trofor, Antigona
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (11):
  • [23] Progressive Fibrosing Interstitial Lung Diseases: A Current Perspective
    Albera, Carlo
    Verri, Giulia
    Sciarrone, Federico
    Sitia, Elena
    Mangiapia, Mauro
    Solidoro, Paolo
    BIOMEDICINES, 2021, 9 (09)
  • [24] Influence of inflammatory mechanisms on the redox balance in interstitial lung diseases
    Lenz, AG
    Hinze-Heyn, H
    Schneider, A
    Behr, J
    Häussinger, K
    Heindl, S
    Stanzel, F
    Maier, KL
    RESPIRATORY MEDICINE, 2004, 98 (08) : 737 - 745
  • [25] Pathogenesis of Interstitial Lung Disease in Children and Adults
    Glasser, Stephan W.
    Hardie, William D.
    Hagood, James S.
    PEDIATRIC ALLERGY IMMUNOLOGY AND PULMONOLOGY, 2010, 23 (01) : 9 - 14
  • [26] Outcomes Following Surgical Lung Biopsy for Interstitial Lung Diseases: A Monocenter Experience
    Millaire, Emilie
    Ouellet, Etienne
    Fortin, Marc
    Martel, Simon
    Milot, Julie
    Bilodeau, Lara
    Conti, Massimo
    Provencher, Steeve
    Dion, Genevieve
    THORACIC AND CARDIOVASCULAR SURGEON, 2022, 70 (07): : 583 - 588
  • [27] Osteopontin as a Biomarker in Interstitial Lung Diseases
    Iturbe-Fernandez, David
    Pulito-Cueto, Veronica
    Mora-Cuesta, Victor M.
    Remuzgo-Martinez, Sara
    Ferrer-Pargada, Diego J.
    Genre, Fernanda
    Alonso-Lecue, Pilar
    Lopez-Mejias, Raquel
    Atienza-Mateo, Belen
    Gonzalez-Gay, Miguel A.
    Cifrian-Martinez, Jose M.
    BIOMEDICINES, 2024, 12 (05)
  • [28] Biologic Treatments in Interstitial Lung Diseases
    Karampitsakos, Theodoros
    Vraka, Argyro
    Bouros, Demosthenes
    Liossis, Stamatis-Nick
    Tzouvelekis, Argyris
    FRONTIERS IN MEDICINE, 2019, 6
  • [29] Management of Fibrosing Interstitial Lung Diseases
    Maher, Toby M.
    Wuyts, Wim
    ADVANCES IN THERAPY, 2019, 36 (07) : 1518 - 1531
  • [30] Interstitial Lung Diseases and the Impact of Gender
    Karampitsakos, Theodoros
    Papaioannou, Ourania
    Katsaras, Matthaios
    Sampsonas, Fotios
    Tzouvelekis, Argyris
    CLINICS IN CHEST MEDICINE, 2021, 42 (03) : 531 - 541